Skip to main content

Closed

ORKA: Oruka Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-27.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio23.76×

Oruka Therapeutics, Inc.

ORKANASDAQ Global Market·USD·Closed

Oruka Therapeutics, Inc.

ORKANASDAQ·USD·Closed

$96.51

−1.38%

$96.51

−$1.35 (1.38%)

52W Range

97thpctl

Volume

0.51×avg

Mkt Cap

3.61BUSD

P/E

-40.4TTM

Div Yield

–ann

52W Range

97thpctl

Volume

0.51×avg

Market Cap

3.61BUSD

P/E Ratio

-40.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings